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The conversion of prion helix 1 from an -helical into
an extended conformation is generally assumed to be an
essential step in the conversion of the cellular isoform
PrPC of the prion protein to the pathogenic isoform
PrPSc. Peptides encompassing helix 1 and flanking se-
quences were analyzed by nuclear magnetic resonance
and circular dichroism. Our results indicate a remark-
ably high instrinsic helix propensity of the helix 1 re-
gion. In particular, these peptides retain significant he-
licity under a wide range of conditions, such as high salt,
pH variation, and presence of organic co-solvents. As
evidenced by a data base search, the pattern of charged
residues present in helix 1 generally favors helical
structures over alternative conformations. Because of
its high stability against environmental changes, helix 1
is unlikely to be involved in the initial steps of the path-
ogenic conformational change. Our results implicate
that interconversion of helix 1 is rather representing a
barrier than a nucleus for the PrPC3PrPSc conversion.
Prion protein, PrP,1 is probably the disease-causing agent of
transmissible spongiform encephalopathies such as bovine
spongiform encephalopathy in cattle or Creutzfeldt-Jakob dis-
ease in man (1). Its cellular form, PrPC, is a highly conserved
cell surface glycoprotein of 230 amino acids expressed in all of
the mammals studied so far as well as in several species of fish
and birds (2, 3). The physiological function of PrPC is not yet
fully understood. PrPC seems to be involved in the maintenance
of proper presynaptic copper levels as well as in protecting
neurons from oxidative stress (4, 5). In addition, the physiolog-
ical function of PrPC could be associated with higher neurolog-
ical functions such as learning and memory (5). According to
the protein-only hypothesis, disease is caused by accumulation
of a misfolded pathogenic isoform, PrPSc, which is the result of
an irreversible large scale conformational change of PrPC. Al-
though PrPC is largely -helical and soluble in polar solvents
and sensitive to protease K digestion, PrPSc consists mostly of
-sheets, is soluble only in nonpolar, denaturing solvents, and
is resistant to digestion with protease K (6). PrPSc forms fibril-
lar aggregates similar to other amyloid fibrils (7). Accumula-
tion of PrPSc aggregates is accompanied by astrocytosis and
gliosis in central nervous tissue, which in turn result in vacu-
oles in the brains of patients.
The solution structures of human PrP-(23–230), huPrP (8),
mouse PrP-(121–231) (9), bovine PrP-(23–230) (10), and Syrian
hamster PrP-(29–231) (11) have been determined by NMR
spectroscopy. They possess a high degree of structural conser-
vation consistent with the high sequence identity of these pro-
teins. Prion proteins consist of a flexible NH2-terminal domain
spanning residues 23–124 (huPrPC-numbering scheme), which
is largely disordered. This region includes an octapeptide se-
quence that is repeated four times from residues 60 to 92 and
that is likely to bind copper (4). This part also contains the
palindromic sequence, AGAAAAGA, which may be involved in
fibrillogenesis (12). The COOH-terminal domain (residues
125–231) adopts a well defined tertiary structure containing
three -helices and a short anti-parallel -sheet. This globular
domain can further be divided into two subdomains, one long
hairpin subdomain (helix 1 and the -sheet) and one purely
-helical subdomain (helices 2 and 3) (13). In contrast, little is
known regarding the structural properties of PrPSc. Epitope
mapping of the PrPSc-specific monoclonal antibody 15B3 sug-
gests a structural rearrangement of the sequence of helix 1
during the conversion reaction (14). A recent low resolution
model derived from electron-crystallographic data proposes in-
corporation of the unstructured domain and the long hairpin
subdomain into a left-handed -helix while the helical subdo-
main is supposed to retain its structure (15). These data sug-
gest that helix 1 has to undergo a major structural rearrange-
ment from an -helix into a structure involving a significant
amount of -sheet (Scheme 1). In addition, helix 1 possesses
several other unique features. Helix 1 extends from Asp-144 to
Met-154 in the mean NMR structure of human prion protein
(8). 6 of these 11 residues are charged at neutral pH making
helix 1 the most hydrophilic helix in all of the known protein
structures (16). Furthermore, helix 1 has very few long range
interactions. Moreover, it has a significant number of solvent-
accessible backbone hydrogen bonds (17). On the basis of com-
putational studies, it has been hypothesized that helix stabili-
zation occurs electrostatically via two intrahelical salt bridges
and a charge distribution interacting favorably with the intrin-
sic dipole moment of the helix (16). To further investigate the
intrinsic conformational propensity of the sequence of helix 1,
we conducted NMR spectroscopic and computational studies of
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several synthetic peptides encompassing helix 1 and flanking
sequences.
EXPERIMENTAL PROCEDURES
Peptides—All of the peptides were purchased from Jerini AG (Berlin,
Germany) as high pressure liquid chromatography-purified freeze-dried
powder containing trifluoroacetate as counterions. Peptides were pro-
tected by an NH2-terminal acetyl group and by amidation at the COOH
terminus to exclude charge effects from free termini. The peptides under
investigation were as follows: huPrP-(110–157) (Ac-KHMAGAAAAGAV-
VGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRY-NH2); huPrP-
(140–158) (Ac-HFGSDYEDRYYRENMHRYP-NH2); and huPrP-(140–
166) (Ac-HFGSDYEDRYYRENMHRYPNQVYYRPM-NH2).
NMR-Spectroscopy—For the preparation of NMR samples, the
freeze-dried peptides were dissolved in H2O/D2O (9:1) buffered by 25
mM sodium acetate for pH 4.5 samples or 10 mM potassium phosphate
for pH 6.5 samples. 0.1% sodium azide was used to prevent bacterial
growth in the sample. Undissolved material was removed by centrifu-
gation, and the pH value of the solution was readjusted. Samples
contained 2,2-dimethyl-2-silapentane-5-sulfonate as internal reference
for proton chemical shifts. Peptide concentrations were determined
photospectrometrically using a molar absorption coefficient 280 of 1280
cm1 per tyrosine residue (18). Spectra were recorded on Bruker
Avance 400 and DRX600 spectrometers with proton frequencies of 400
and 600 MHz, respectively. Quadrature detection in f1 was achieved
using States-time-proportional phase incrementation or the echo-anti-
echo method. The solvent signal was suppressed by the WATERGATE
W5 method (19, 20) or by excitation sculpting (21). Two-dimensional
1H-1H TOCSY (22) spectra with mixing times of 40 and 80 ms, respec-
tively, and two-dimensional 1H-1H NOESY (23) spectra with mixing
times of 150 and 300 ms, respectively, were recorded at 283 K. The
temperature was calibrated with methanol (24). Data were processed
with the software package NDEE (Spin Up Inc., Dortmund, Germany).
Typically, a sine-squared window function shifted by /3 was applied in
both dimensions with zero-filling to 1024 data points in f1 and 4096
data points in f2. Base-line correction (25) was performed using home-
written software. Sequential assignments were achieved using the
main-chain-directed strategy devised by Wu¨thrich et al. (26). Assign-
ment of secondary structure elements was achieved using the 1H
chemical shift index (CSI) method described by Wishart et al. (27).
Random coil chemical shifts derived from Ac-GGXGG-NH2-type model
peptides acquired under acidic conditions and their corresponding cor-
rection factors correcting for effects from the local amino acid sequence
were employed (28, 29). For studies at higher pH values, random coil
chemical shifts for Asp and Glu were taken from Ac-GG(D/E)AGG-NH2
peptides measured at pH 5 (30).
CD Spectroscopy—CD spectra were recorded on a Jasco J810 instru-
ment using quartz cells with path lengths of 0.1 and 1 mm, respectively.
Samples were prepared from the NMR samples by dilution with appro-
priate buffers. Spectra were taken at 283 K. Typically, four scans over
the wavelength range 200–260 nm were acquired with a stepwidth of
0.5 nm, an integration time of 4 s, and a bandwidth of 1 nm. Helix
contents were estimated from the mean residual ellipticity at 222 nm
(31).
Pattern Search—Proteins containing a pattern of charged residues
similar to that of huPrP helix 1 were identified by a pattern search
against the Protein Data Bank (PDB) filtered at 95% sequence identity
(PDB95) using the program PATTINPROT (npsa-pbil.ibcp.fr/cgi-bin/
npsa_automat.pl?page  /NPSA/npsa_pattinprot.html). In addition to
the pattern [DE]-X-X-[DE]-[RK]-X-X-[RK] present in huPrP, three ad-
ditional patterns generated by permutation of the charged residues
([DE]-X-X-[RK]-[RK]-X-X-[DE],[RK]-X-X-[DE]-[DE]-X-X-[RK],and[RK]-
X-X-[RK]-[DE]-X-X-[DE]) were used as input. All four patterns are
formed by two overlapping subpatterns, each containing a positively
and a negatively charged residue four positions apart in sequence. In
addition, the patterns [DE]-X-X-[DE]-[RK]-X-X-[RK]-[DE], [DE]-X-X-A-
[RK]-X-X-[RK]-[DE], and [DE]-X-X-[DE]-[RK]-X-X-[RK]-A were used to
assess the effect of point mutations on helix propensity. Secondary
structure of the residues forming these patterns was analyzed using
home-written software that correlates the PATTINPROT output (PDB
code and sequence position of the pattern) with the secondary structure
of the corresponding residues obtained from dictionary of secondary
structure of proteins analysis (32). The type of secondary structure and
the accessible surface area for each position of the pattern and the
flanking residues were calculated.
RESULTS AND DISCUSSION
Stability of Helix 1 Is Independent of Neighboring Sequen-
ces—The effect of flanking sequences on the conformational
properties of helix 1 in the three peptides, huPrP-(110–157),
huPrP-(140–158), and huPrP-(140–166), was analyzed by
means of CD and NMR spectroscopy. Because of the low solu-
bility of huPrP-(110–157) and huPrP-(140–166) at near-neu-
tral pH values, investigations had to be carried out at pH 4.5.
Information on the preference for a particular secondary struc-
ture was determined using 1H chemical shifts (27, 28). In all of
the three peptides, chemical shift analysis indicates the pres-
ence of helical conformation in the region 145–155, which is in
good agreement with the position of helix 1 in the solution
structure of huPrP-(90–231) (Table I). 1H chemical shifts for
helix 1 in the three peptides show no significant differences,
implying that the sequences flanking helix 1 neither contribute
to its stability nor to its conformational preference. However,
sequences adjacent to helix 1 behave as free flight random coils.
In particular, the sequence 129–131, forming -strand 1 in the
native PrPC structure, does not show any sign of populating an
extended conformation (Fig. 1, A and B). Moreover, the NH2-
terminal alanine-rich region, which is thought to play a key
role in fibril formation (33), does not populate extended confor-
mations nor does it form helical conformations as might be
expected from the high content of alanine residues. An excep-
tion from random coil behavior is found for the sequence prior
to the NH2 terminus of helix 1 in which a small population of
extended conformation can be found. However, the absence of
tertiary NOE-cross-peaks in the peptides suggests high confor-
mational flexibility.
CD spectra of the peptides huPrP-(140–158) and huPrP-
(140–166) show a broad negative band at 208 nm with a shoul-
der at 216 nm, indicating the presence of some regular second-
ary structure, whereas the spectrum of huPrP-(110–157)
resembles more that of a random coil (Table I, full spectra are
shown in supplemental information). The helix content of the
peptides, as estimated from the residual ellipticity at 222 nm,
amounts to 4% for huPrP-(110–157), 7% for huPrP-(140–158),
and 6% for huPrP-(140–166) (Table I). CD spectroscopy shows
consistently lower helix content than NMR spectroscopy be-
cause the CD signal represents an average over the entire
peptide while NMR reports the helix content at a particular
position. In addition, the high number of tyrosine residues in
the peptides may lead to non-trivial CD spectra, thereby caus-
ing misestimation of secondary structure content (34).
To further explore the conformational properties as a func-
SCHEME 1. Schematic view of the structural conversion of PrPC
into pathogenic PrPSc. A main problem in prion diseases is to un-
derstand the conformational change from cellular PrPC into the amy-
loid-forming infectious PrPSc conformation. Shown are the structure of
the carboxyl-terminal domain of PrPC (solution structure, PDB entry
1QLX (8)) and a structural model of PrPSc for the corresponding amino
acid sequence. This schematic model of PrPSc is based on low resolution
electron crystallography data and homology modeling as proposed by
Wille et al. (15). Secondary structure elements are color-coded according
to their occurrence in the solution structure of the cellular conformation
(red  -helix; cyan  -sheet). Whereas helices 2 and 3 remain helical
in PrPSc, helix 1, which is encircled in the structure of PrPC, is incor-
porated into the left-handed -helix that builds up the amino-terminal
part of PrPSc. The images were created with WebViewer 5.0 lite (Accel-
rys, San Diego, CA).
Structural Studies of PrP Helix 150176
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tion of varying environment, peptides were investigated in the
presence of the organic co-solvents trifluorethanol (TFE) and
acetonitrile. TFE is known to stabilize the helical conformation
of peptides (35), whereas acetonitrile has been shown to en-
hance fibril formation in peptides (36), presumably by favoring
extended conformations. To test whether helix 1 can be further
stabilized, huPrP-(140–158) was studied in the presence of
40% TFE at pH 6.5. Judged by the mean residual ellipticity at
222 nm in the CD, the helix content of the peptide has nearly
tripled compared with the TFE-free sample at pH 6.5. This
finding was confirmed by NMR spectroscopy indicating helical
conformation for residues 144–156 with an upfield deviation of
the 1H resonances, which is on average 0.5 ppm larger than
that for the TFE-free sample (Fig. 1C). These observations
show that the apparent rise in helix content indicated by CD
spectroscopy is attributed to the higher population of helical
conformers for residues 145–156 rather than to elongation of
helix 1. Because huPrP-(110–157) contains the first -strand
TABLE I
Average helix content of the investigated peptides
n/a, not available.
CDa NMR (total)b NMR-(144–154)c AGADIRd
huPrP-(110–157), pH 4.5 0.04 0.14 0.43 0.04
huPrP-(140–158), pH 4.5 0.07 0.27 0.46 0.1
huPrP-(140–166), pH 4.5 0.06 0.21 0.46 0.07
huPrP-(140–158), pH 2.0 0.08 0.17 0.27 0.03
huPrP-(140–158), pH 6.5 0.14 0.34 0.58 0.14
huPrP-(140–158), pH 4.5, 250 mM NaCl n/a 0.24 0.41 0.1
huPrP-(140–158), pH 4.5, 500 mm NaCl n/a 0.28 0.45 0.09
huPrP-(140–158)D147A, pH 4.5 0.13 0.34 0.52 0.11
huPrP-(140–158)E152A, pH 4.5 0.09 0.29 0.44 0.07
huPrP-(110–157), 40% acetonitrile 0.08 0.03 0.37 n/a
huPrP-(110–157), 40% TFE 0.11 n/a n/a n/a
huPrP-(140–158), 40% TFE 0.32 0.37 0.66 n/a
a Estimated from 222 nm (31).
b Estimated from the average secondary structure shift for all of the residues.
c Estimated from the average secondary structure shift for residues 144–154.
d Calculated by AGADIR (40, 41, 42).
FIG. 1. Context and solvents de-
pendence of 1H secondary shifts. A,
comparison of the 1H shifts for the region
110–166. Difference of 1H chemical
shifts to the respective random coil values
for the peptides huPrP-(110–157) (white),
huPrP-(140–158) (black), and huPrP-
(140–166) (hatched). B, comparison of the
1H secondary shifts for the region 140–
157. White bars correspond to huPrP-
(110–157), black bars correspond to
huPrP-(140–158), and hatched bars cor-
respond to huPrP-(140–166). The dashed
line at 0.1 ppm indicates the cutoff
value for the assignment of extended sec-
ondary structure. The dashed line at0.1
ppm indicates the cutoff value for the as-
signment of helical secondary structure in
the regular CSI protocol. C, secondary
shifts of huPrP-(110–157) in presence of
organic co-solvents. Data of huPrP-(110–
157) in the presence of 40% acetonitrile
are shown in white and those in 40% TFE
are depicted in black.
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and the potentially amyloidogenic palindrome AGAAAAGA in
addition to helix 1, this peptide was investigated in the pres-
ence of 40% acetonitrile. However, no evidence for the peptide
populating extended conformations (Table I) could be obtained.
1H chemical shifts still show helical conformation for residues
145–156 (Fig. 1C), but the 1H resonances are slightly shifted
to lower field compared with the acetonitrile-free sample, indi-
cating destabilization of the helical conformation. Although
this finding holds true for the entire sequence, low field shifts
were too small to be classified as extended conformations.
Interactions Contributing to the Stability of Helix 1—The
sequence of helix 1 exhibits several features that potentially
stabilize helical conformations, either by electrostatic (charge-
charge or charge-dipole) or by aromatic interactions. Residue
Asp-144 acts as a N-cap for the helix stabilizing it by forming a
hydrogen bond to an exposed backbone amide located NH2-
terminally of the helix (37). Furthermore, three negative
charges (Asp-144, Glu-146, and Asp-147) stabilize helix 1
through favorable electrostatic interactions with the helix di-
pole. Similarly, the COOH terminus is stabilized by the posi-
tive charges of Arg-151, His-155, and Arg-156. In addition,
three pairs of oppositely charged amino acids (Asp-147/Arg-
151, Asp-144/Arg-148, and Arg-148/Glu-152), each spaced four
residues apart in sequence, potentially stabilize helix 1 by the
formation of intrahelical salt bridges (38).
Because the stability of helix 1 proved to be insensitive to its
immediate sequence neighborhood, further investigations were
conducted using the shortest and most soluble peptide, huPrP-
(140–158). The contribution of charged residues to helix sta-
bility was addressed by changing the pH to 2.0 and 6.5, respec-
tively. CD and NMR spectra at pH 6.5 are similar to those
recorded at pH 4.5. Only very small 1H shifts to a higher field
point toward a marginally more stable helical conformation at
pH 6.5 (Fig. 2A). In contrast, spectra recorded at pH 2.0 exhibit
a marked decrease in helix content (Table I). However, the
mean residual ellipticity at 222 nm as well as the 1H chemical
shifts shows that the peptide retains some residual helicity
even under acidic conditions. Chemical shift analysis reveals
that no shortening of helix 1 occurs and that no part of the helix
is preferentially destabilized. Instead, destabilization to ap-
proximately the same extent is observed over the entire helix
(Fig. 2A). However, over the whole pH range investigated, no
FIG. 2. Electrostatic influences on
1H secondary shifts. A, pH dependency
of the 1H secondary shifts for huPrP-
(140–158). pH 4.5 corresponds to white
bars, pH 6.5 corresponds to black bars,
and pH 2.0 corresponds to hatched bars.
B, influence of ionic strength on the 1H
secondary shifts of huPrP-(140–158).
Data at pH 4.5 are shown in the absence
of NaCl (white) and in the presence of 250
mM NaCl (black) and 500 mM NaCl
(hatched), respectively. C, secondary
structure shifts of huPrP-(140–158) mu-
tants. 1H chemical shifts at pH 4.5 are
shown for huPrP-(140–158) wild type
(white), huPrP(140–158)D147A (black),
and huPrP(140–158)E152A (hatched).
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indications for population of extended conformers could be
found. None of the NOESY spectra shows long range interac-
tions, again indicating high conformational flexibility.
This pH dependence of helix stability can be attributed to the
change in the charge distribution of the peptide. At pH 6.5, all
of the acidic and basic residues of the peptide are charged. The
negative charges of Asp-144, Glu-146, and Asp-147 as well as
the positive charges of Arg-151 and Arg-156 can exert their
stabilizing influence on the helix macrodipole. Furthermore,
i,i4 spaced oppositely charged residues potentially form sta-
bilizing salt bridges. Lowering the pH to 4.5 did not lead to
significant destabilization, indicating that aspartate and glu-
tamate residues are still carrying negative charges. At pH 2.0,
all of the acidic residues are protonated, reducing salt bridges
to charge-dipole interactions and charge-dipole to dipole-dipole
interactions. This reduction of the strength of attractive elec-
trostatic interactions in combination with repulsion by posi-
tively charged residues is suggested to be responsible for the
decrease in helix content at pH 2.0.
In particular, the putative salt bridges Asp-147/Arg-151 and
Arg-148/Glu-152 are of interest with respect to the stability of
helix 1. Therefore, huPrP-(140–158) was investigated at pH 4.5
in the presence of 50, 250, and 500 mM NaCl, respectively. No
changes were observed with 50 mM NaCl compared with the
salt-free peptide (data not shown). 1H chemical shifts also
indicate helical conformation for residues 145–155 at both
higher concentrations of NaCl (Fig. 2B). However, the popula-
tion of the helix is nearly identical to that of the salt-free
sample. In particular, the conformation of residues potentially
involved in intrahelical salt bridges is not influenced by NaCl
concentrations up to 500 mM. This might be because of the
mutual cancellation of two opposite effects. Whereas increas-
ing the salt concentration stabilizes helices by screening the
helix macrodipole (39), solvent-exposed interactions between
charged side chains are weakened at higher ionic strengths. To
probe for the role of the putative salt bridges without being
influenced by the abovementioned effects, we mutated amino
acids contributing to the putative intrahelical salt bridges to
huPrP-(140–158)D147A and huPrP-(140–158)E152A. The CD
spectrum of huPrP-(140–158)E152A is virtually identical to
the spectrum of the wild-type sequence, whereas the spectrum
of huPrP-(140–158)D147A even exhibits an increase in helix
population as judged from the mean residual ellipticity at 222
nm (Table I). CD results are in good agreement with 1H
chemical shifts analysis. Shifts for residues 145–155 of huPrP-
(140–158)D147A (Fig. 2C) are nearly identical to the wild-type
peptide with the exception of residues Tyr-145, Glu-146, and
Ala-147, which are shifted to slightly higher field, indicating a
marginally higher population of helical conformers. Similarly,
the helix extends from Tyr-145 to His-155 in huPrP-(140–
158)E152A. Again, 1H secondary chemical shifts are compa-
rable with those of the wild-type peptide with the exception of
a small downfield shift of approximately 0.05 ppm at the site of
the mutation, indicating slight destabilization of the helix at
this position (Fig. 2C). Helix content and relative secondary
shifts for both mutations are consistent with predictions made
by AGADIR (Table I) (40, 41, 42).
Disruption of salt bridges by mutation causes destabilization
of the helix, which is compensated for by the high helix pro-
pensity of the substituent alanine. The effects of the mutations
are confined to the immediate vicinity of the site of mutation
(Fig. 2). Because the effects at the sites of the mutations are
also rather small, indicating practically no change in helix
population, experimental helix propensity scales (43) can be
employed to estimate the stabilizing energy contributed by the
amino acid residue exchanged. Exchange of a charged gluta-
mate with alanine should result in a stabilization of 0.3–0.6
kcal/mol in the absence of additional interresidual interactions.
The fact that only a small local destabilization of helix 1 in the
E152A peptide was observed therefore implies the existence of
a helix-stabilizing interaction in the wild-type peptide being at
least equal to the energetic difference in helix propensities
between glutamate and alanine. Most probably, this stabiliza-
tion can be attributed to the putative Arg-148/Glu-152 intra-
helical salt bridge. In the case of the D147A mutant, the ex-
perimental helix propensity scales predict a stabilization of
0.6–1.10 kcal/mol for the aspartate-alanine exchange. Al-
though a slight stabilization is observed for this mutant, a more
pronounced gain in local helicity is expected in the absence of
any stabilizing interactions of Asp-147. However, because
AGADIR predicts a stabilizing effect for Arg-151, the potential
binding partner of Asp-147, a salt bridge Asp-147/Ar-151 is
likely to exist. Our results are in line with recently published
unfolding data on the Syrian hamster PrP-(23–231) mutants
Asp144-(Asn/Ala) and Asp-147(Asn/Ala), respectively, which do
not lead to significant destabilization of the full-length prion
protein but exhibit an increased conversion efficiency in vitro
(44). Most probably, both aspartate residues are involved in
local interactions affecting helix stability (Asp-144, N-cap, he-
lix macrodipole; Asp-147, i,i4 salt bridge), which when dis-
rupted do not cause a global effect on the whole protein but
which locally destabilize helix 1, rendering it more susceptible
for a conformational change, which in turn may cause the
observed differences in conversion efficiency.
Further evidence for the stabilizing effect of i,i4 charge-
charge interactions comes from a pattern search of such inter-
actions in three-dimensional structures deposited in the PDB.
Systematic analysis of all of the known structures deposited in
the PDB resulted in a total of 2799 hits for the pattern [DE]-
X-X-[DE]-[RK]-X-X-[RK] and its permutations. 70% of the
residues adopt helical conformation. Permutation of charged
amino acids in the input pattern resulted in similar helix
contents of 64–80% showing that permutation of the charged
residues has no significant influence on the preferred type of
secondary structure. For that reason, the results from the
searches with all four patterns were merged for subsequent
analysis.
The highest helical propensity is found for those residues form-
ing the central part of the pattern. Helix propensity steadily
decreases toward the ends of the pattern and is significantly
lower for the flanking residues (Fig. 3). Approximately 10% of the
flanking residues form -strands while this structural element is
almost completely absent (2%) from the central residues of the
pattern. An analysis of structures containing the pattern in a
-sheet conformation is of particular interest with respect to
interactions of charged residues in this type of secondary struc-
ture and thus to the principles of PrPSc formation. Interestingly,
most structures exhibiting -sheets in this region do not form one
continuous -strand. Instead, two -strands in the flanking re-
gions of the pattern are formed while the center part adopts a
single turn of helix or a turn connecting both strands, which is
consistent with the low -propensity observed for the middle part
of the pattern (Fig. 3). Most of these turns are highly solvent-
exposed with the charged side chains pointing out to the solvent
instead of showing a regular pattern of intramolecular electro-
static interactions.
The analysis was repeated for the full pattern of potential
salt bridge-forming residues ([DE]-X-X-[DE]-[RK]-X-X-[RK]-
[DE]) without permutations, yielding a total of 146 hits. No
significant influence of the additional charge could be observed.
The proportion of residues in helical conformation still
amounts to 77%. To assess the effects of point mutations dis-
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rupting the salt bridge network, the patterns [DE]-X-X-A-[RK]-
X-X-[RK]-[DE] modeling the D147A mutation and [DE]-X-X-
[DE]-[RK]-X-X-[RK]-A modeling the E152A mutation were
analyzed using the same procedure. The number of hits de-
creased to 53 for the D147A pattern and 39 for the E152A
pattern. The probability of finding residues of these patterns in
helical conformation is nearly unchanged in comparison to the
wild-type pattern (83% for D147A and 77% for E152A). Again,
the central part of the pattern has the lowest probability
to adopt extended conformations, whereas this probability rises
toward the termini of the pattern. However, the small num-
ber of occurrences of the mutations in the patterns points
toward an involvement of these residues in salt bridge-like
interactions.
Although electrostatic interactions play an important role in
helix 1, they are unlikely to be the sole reason for the high helix
content in PrP helix 1. It has been shown that i,i4 hydropho-
bic interactions stabilize helices (28, 45, 46). PrP helix 1 con-
tains a pair of i,i4-spaced tyrosine residues in positions 145
and 149, respectively. In the NMR structure of human PrP, the
aromatic side chains are oriented perpendicular toward each
other (8). Most probably, an aromatic ring hydrogen of Tyr-149
binds to a carbon of the aromatic ring of Tyr-145 in a weak
hydrogen bond-like interaction (47, 48). A stabilizing interac-
tion of Tyr-145 and Tyr-149 could be confirmed by AGADIR.
The sequence of the peptide under investigation also contains
Phe-141, which potentially could interact with Tyr-145. De-
spite not being part of the helix in either the NMR structure of
the entire protein or the isolated peptide, Phe-141 forms an
aromatic interaction similar to Tyr-145/Tyr-149 with Tyr-150.
Thus, a cluster of aromatic residues is formed in the peptide,
which is solvent-exposed to a large part even in the structure of
PrP. In addition to its importance for the stability of helix 1
itself and for the attachment of helix 1 to helices 2 and 3, this
cluster of aromatic residues may play an important role for the
binding of potential therapeutic drugs such as quinacrine (49).2
Our data underline the importance of interleaved placement
of i,i4 electrostatic and aromatic interactions for the forma-
tion of stable helices. However, close inspection of the chemical
shifts in helix 1 reveals that the helix is more stable at its
termini than in its central part. A steric reason might be the
proximity of two tyrosine residues in the central part that carry
large bulky side chains. Recently, it has been shown that se-
quences containing residues with bulky side chains in close
proximity have a tendency to adopt extended conformations in
disordered polypeptides to minimize repulsion because of steri-
cal hindrance (50). The local destabilizing character of Tyr-150
is underlined by AGADIR, which predicts an increase in helix
population of 60% for a Y150A mutation.
The Interactions Rendering PrP Helix 1 Stable Are Respon-
sible for Residual Helicity and Turn Formation in Disordered
States—Residual helicity is retained even under denaturing
conditions because it was also observed in a highly polar region
(E52-AEMKA-S58) in acid-unfolded and in urea-denatured
apomyoglobin (45, 50). Remarkably, this sequence, which in-
cludes helix D of apomyoglobin, has an even higher content of
residual helix than helix H of apomyoglobin, which has been
shown to have a very high intrinsic helix propensity in peptide
studies. Similar to helix 1 of PrP, a pattern of favorable i,i4
interactions between charged and other polar residues (Lys50-
Glu54, Glu52-Lys56, Glu54-Ser58) can be found. In addition, non-
polar i,i4 interactions are present (Thr51-Met55, Ala53-Ala57,
Ala57-Leu61). In contrast to PrP helix 1, charges in this se-
quence of apomyoglobin do not favorably interact with the helix
macrodipole and the non-polar interactions do not involve ar-
omatic residues, which in summary is likely to result in the
higher helix propensity of PrP helix 1. Interestingly, high re-
sidual helix contents can also be observed in the polar sequence
stretch M57-SEED-L62 of unfolded apo-plastocyanin (51). In
contrast to apo-myoglobin, this sequence codes for a loop in the
native protein, indicating that highly polar amino acid se-
quences exhibit a strong helix-forming tendency per se. How-
ever, another short peptide from apomyoglobin spanning the
CD turn forms a turn conformation in aqueous solution that
includes a strong salt bridge (Asp-44/Arg-47). Therefore, polar
sequence patterns are not only involved in helix formation,
they may also contribute to turn formation. This is in line with
our findings from the pattern searches that in cases of non-
helical conformers the central part of helix 1 forms a turn in
most cases.
Implications for the Conversion Reaction—Our observations
consequently lead to the question of how helix 1, although
being remarkably stable against environmental and muta-
tional changes, is involved in the conformational conversion of
PrPC to PrPSc. In particular, helix 1 has to undergo complete
structural rearrangement from helical conformation to a
-sheet conformation according to recent structural model de-
rived from cryoelectron crystallography of two-dimensional
crystals of prion protein (15). In view of its high stability, it is
highly unlikely that helix 1 acts as initial starting point for the
conversion as proposed previously (16). Because helix 1 is em-
bedded in parts in the structure that already adopt in large
part a -sheet or extended conformation in PrPC, it is likely
that this helix is one of the final parts of prion protein that
changes its structure in a local unfolding event. Thus, helix 1
may actually delay propagation of a structural change that is
initiated somewhere else in the protein. This is in agreement
with mutation studies in which helix 1 was deleted (PrP-(121–
231)-	H1 (52) and PrP106 (53)). In both cases, strongly de-
creased stability was observed. In particular, PrP106 is largely
unstructured and precipitates spontaneously forming -sheet
conformations. Moreover, it could recently be shown that the
monoclonal antibody ICSM 18, which recognizes residues 146–
159 of murine PrPC, inhibits prion replication and delays de-
velopment of prion disease (54).
In this context, it is interesting to observe that chemical
2 A. Frank, J. Ziegler, P. Ro¨sch, and S. Schwarzinger, unpublished
observations.
FIG. 3. Helix and sheet propensities of residues forming the
pattern [DE]-X-X-[DE]-[RK]-X-X-[RK]. Positions 1–8 indicate the
residues 1–8 of the pattern, positions 3 to 1 indicate the three
residues preceding the pattern, and positions 1 to 3 indicate the
three residues following the pattern. Helix and sheet propensities were
calculated from all of the known protein structures containing the
pattern as described under “Experimental Procedures.”
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shifts of residues immediately preceding helix 1, in particular
His-140 and Gly-142, indicate the presence of some helical
structure at pH 6.5 (Fig. 2A). This residual helicity is lost upon
decreasing the pH to 4.5, thereby increasing conformational
flexibility in this part of the protein, which suggests that the
protonation state of His-140 might influence the secondary
structure in this region. In fact, peptides that contain the bulky
residues IIHF immediately preceding Gly-142, but do not in-
clude helix 1, form fibrils more readily than for example pep-
tides containing only the alanine-rich part preceding the
COOH-terminal domain of PrP.3 This raises the possibility for
a mechanism of PrPSc formation in which a nucleus for oli-
gomerization is formed by hydrophobic contacts at solvent-
exposed parts of the protein, such as I138-IHF or -strand 1
(Tyr-128-ML). Contact formation and subsequent extension of
the -sheet nucleus lead to a change in the chemical environ-
ment of helix 1 causing it to unfold at least partially and change
into a conformation presumably consisting of sheet- and turn-
elements. The conversion may be further facilitated by changes
in the environment such as a decrease of the pH.
Summary—We showed that helix 1 is remarkably stable
over a wide range of conditions. No set of solvent conditions
applied was sufficient to completely disrupt the helical confor-
mation. As the model of PrPSc devised by Wille et al. (15)
proposes the incorporation of helix 1 into the parallel -helix
forming the main part of prion amyloid, the high stability of
helix 1 could be part of a barrier needed to prevent the spon-
taneous conversion of PrPC to PrPSc (55). Conversion of helix 1
into an extended sheet structure is possibly induced by means
of a changed tertiary environment after the prion transforma-
tion has been initiated in some other part of the protein. The
nature of this initiation site, however, remains unclear. For
both regions proposed to be involved in the early stages of
transformation, the stretch of apolar residues in the region
110–120 (12, 33) and the short anti-parallel -sheet of the
prion protein, no indication for the existence of stable extended
conformers could be found. This might be because of the higher
flexibility of the used model peptides compared with the full-
length prion protein in which where tertiary interactions sta-
bilize the two -strands of PrPC. In addition, we show that helix
1 can be further stabilized by TFE despite its high intrinsic
stability. The potential for additional stabilization makes helix
1 an interesting target for drug design. For example, short
model peptides like huPrP-(140–158) could be used to assess
potential helix-stabilizing effects of agents discussed for anti-
prion medications.
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